Ex-Cas­ca­di­an chief Scott My­ers lands at Bio­Clin; Ko­di­ak woos Genen­tech vet Ja­son Ehrlich for CMO role

→ Scott My­ers and Julie East­land, two of the top ex­ecs head­ed out as Cas­ca­di­an Ther­a­peu­tics got ab­sorbed in­to Seat­tle Ge­net­ics, have both set­tled at Bio­Clin Ther­a­peu­tics. Stay­ing in fa­mil­iar roles, My­ers has been named CEO while East­land is CFO and chief busi­ness of­fi­cer. My­ers, who pre­vi­ous­ly held man­age­ment po­si­tions at UCB and J&J be­fore tak­ing the helm of a med­ical de­vice com­pa­ny, suc­ceeds Bio­Clin founder Stephen Lau. The ap­point­ments are an­nounced as the San Le­an­dro, CA-based biotech is gear­ing up for reg­is­tra­tional tri­als of its lead com­pound, vo­fa­tam­ab (B-701).

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER